Submissions are open for the upcoming issue.

Molecular Medicine Peer-reviewed scientific journal

Found: 7

ОБЗОР2026 · pp. 59–66

Molecular and biological characteristics of tumor cells in testicular embryonal carcinoma explants

Introduction. Personalized treatment strategies for embryonal carcinoma, a germ cell tumor, are crucial due to the inherent heterogeneity of the tumor. Existing in vitro models inadequately reflect the native tumor microenvironment. Ex vivo organ culture (EVOC…

10.29296/24999490-2026-03-08Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 3–9

Expression of immune checkpoints by tumor microenvironment Т-lymphocytes in colon cancer

The study of immune checkpoint expression by tumor microenvironment T-lymphocytes is necessary for understanding the pathophysiological mechanisms of tumor immunosuppression, as well as for the development of new methods of targeted therapy for colorectal canc…

10.29296/24999490-2025-06-01Details ↗
ОБЗОР2025 · pp. 27–33

NEW DIAGNOSTIC BIOMARKERS FOR EARLY STAGES OF CUTANEOUS T-CELL LYMPHOMA

Currently, the diagnosis of early stages of cutaneous T-cell lymphomas (CTCL) is one of the most challenging tasks in dermatology. This review is devoted to the analysis of new immunohistochemical (IHC) markers that could be considered diagnostic for the detec…

10.29296/24999490-2025-01-03Details ↗
ОБЗОР2024 · pp. 3–12

Immune microenvironment in hepatocellular carcinoma: current concepts and the role of blockade of immune checkpoints

Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver. The specificity of the immune microenvironment of an organ limits the possibilities of traditional therapeutic and surgical approaches to treatment, therefore one of the mo…

10.29296/24999490-2024-01-01Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2023 · pp. 40–48

EXOSOMAL MIRNAS AS POSSIBLE PREDICTORS OF IMMUNE CHECKPOINT INHIBITORS THERAPY RESPONSE IN CLEAR CELL RENAL CELL CARCINOMA

Despite significant advance in clear cell renal cell carcinoma treatment, immune checkpoint inhibitors (ICIs) still have limited therapeutic efficacy. Taking into account the resistance to immunotherapy, observed in malignant neoplasms, the search for predicti…

10.29296/24999490-2023-04-06Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2023 · pp. 56–60

THE LEVEL OF IMMUNE CHECKPOINT CO-INHIBITORS IN TUMOR TISSUE IN PATIENTS WITH COLON TUMOR

Introduction. A high level of checkpoint co-inhibitors in the tumor microenvironment plays an important role in inhibiting the local immune response, which contributes to the growth and progression of cancer. The aim of the study. We aimed to determine immune …

10.29296/24999490-2023-01-08Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2020

CELLULAR MICROENVIRONMENT OF UVEAL MELANOMA: CLINICAL AND MORPHOLOGICAL CORRELATIONS AND PREDICTORS OF BAD PROGNOSIS

Introduction. Uveal melanoma is a malignant neoplasm of neuroectodermal origin, prone to early metastasis. The tumor microenvironment, including «inflammatory cells» and connective tissue cells, affects its progression, angiogenesis and metastasis. Purpose. To…

10.29296/24999490-2020-03-04Details ↗

Article search and quick navigation

Navigation